Correlation Between Pfizer and Emergent Biosolutions

Can any of the company-specific risk be diversified away by investing in both Pfizer and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Emergent Biosolutions, you can compare the effects of market volatilities on Pfizer and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Emergent Biosolutions.

Diversification Opportunities for Pfizer and Emergent Biosolutions

0.76

Correlation Coefficient

Pfizer  Emergent Biosolutions

Poor diversification

The 3 months correlation between Pfizer and Emergent is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Pfizer i.e., Pfizer and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between Pfizer and Emergent Biosolutions

Considering the 90-day investment horizon Pfizer is expected to generate 6.68 times less return on investment than Emergent Biosolutions. But when comparing it to its historical volatility, Pfizer Inc is 4.21 times less risky than Emergent Biosolutions. It trades about 0.06 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  492.00  in Emergent Biosolutions on May 1, 2025 and sell it today you would earn a total of  158.00  from holding Emergent Biosolutions or generate 32.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Emergent Biosolutions

Pfizer Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Emergent Biosolutions

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Emergent Biosolutions

The main advantage of trading using opposite Pfizer and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.

The idea behind Pfizer Inc and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.